Biomolecules | Free Full-Text | The Bcl-2 Family: Ancient Origins, Conserved Structures, and Divergent Mechanisms
Interplay of Bcl-2 Proteins Decides the Life or Death Fate
Cooperation of BH3-only proteins in killing neurons
Targeting BCL-2 regulated apoptosis in cancer | Open Biology
Ancient and conserved functional interplay between Bcl-2 family proteins in the mitochondrial pathway of apoptosis | Science Advances
Basal Patologi KU - BAD, BID and PUMA proteins shift the balance between the pro-apoptotic and anti-apoptotic family members by neutralizing the actions of anti-apoptotic proteins like BCL2 and BCL-XL, thereby promoting
Multimodal Interaction with BCL-2 Family Proteins Underlies the Proapoptotic Activity of PUMA BH3 - ScienceDirect
The BCL-2 protein family, BH3-mimetics and cancer therapy | Cell Death & Differentiation
Cells | Free Full-Text | Restoring Apoptosis with BH3 Mimetics in Mature B-Cell Malignancies
A) Bcl-2 family member effector proteins (Bax and Bak) oligomerize and... | Download Scientific Diagram
Dysregulation of BCL-2 family proteins by leukemia fusion genes
Experimental Characterization of the Binding Affinities between Proapoptotic BH3 Peptides and Antiapoptotic Bcl‐2 Proteins - Kong - 2018 - ChemMedChem - Wiley Online Library
Interplay of Bcl-2 Proteins Decides the Life or Death Fate ~ Fulltext
PUMA-mediated apoptosis. PUMA is induced by a wide range of death... | Download Scientific Diagram
Bcl-2 - Wikipedia
Targeting BCL-2 regulated apoptosis in cancer | Open Biology
BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy | SpringerLink
Cancers | Free Full-Text | Targeting Mitochondrial Apoptosis to Overcome Treatment Resistance in Cancer
Efficacy and specificity of inhibitors of BCL-2 family protein interactions assessed by affinity measurements in live cells | Science Advances
A model for PUMA-mediated apoptosis. PUMA activates Bax/Bak indirectly... | Download Scientific Diagram
PUMA decreases the growth of prostate cancer PC-3 cells independent of p53
Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance | Cell Death & Disease
PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors
